# Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy

> **NCT03450252** · NA · COMPLETED · sponsor: **Barts & The London NHS Trust** · enrollment: 17 (actual)

## Conditions studied

- Cardiomyopathy, Hypertrophic

## Interventions

- **DEVICE:** Active pacing
- **DEVICE:** Back-up pacing

## Key facts

- **NCT ID:** NCT03450252
- **Lead sponsor:** Barts & The London NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-09
- **Primary completion:** 2023-01-20
- **Final completion:** 2023-01-20
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03450252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03450252, "Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03450252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*